兔抗CD274多克隆抗体

Background:

This gene encodes an immune inhibitory receptor ligand that is expressed by hematopoietic and non-hematopoietic cells, such as T cells and B cells and various types of tumor cells. The encoded protein is a type I transmembrane protein that has immunoglobulin V-like and C-like domains. Interaction of this ligand with its receptor inhibits T-cell activation and cytokine production. During infection or inflammation of normal tissue, this interaction is important for preventing autoimmunity by maintaining homeostasis of the immune response. In tumor microenvironments, this interaction provides an immune escape for tumor cells through cytotoxic T-cell inactivation. Expression of this gene in tumor cells is considered to be prognostic in many types of human malignancies, including colon cancer and renal cell carcinoma. Alternative splicing results in multiple transcript variants.

Applications:

ELISA, WB, IHC

Name of antibody:

CD274

Immunogen:

Synthetic peptide of human CD274

Full name:

CD274 molecule

Synonyms:

B7-H; B7H1; PDL1; PD-L1; PDCD1L1; PDCD1LG1

SwissProt:

Q9NZQ7

ELISA Recommended dilution:

5000-10000

IHC positive control:

Human esophagus cancer and Human liver cancer

IHC Recommend dilution:

40-200

WB Predicted band size:

33 kDa

WB Positive control:

A549,Raji,RAW264.7,Jurkat and HepG2 cell lysates

WB Recommended dilution:

200-1000